Please login to the form below

Not currently logged in
Email:
Password:

Next steps for former head of EMA

Dr Thomas Lönngren joins new European regulatory and market access company

Having completed his ten-year appointment as executive director of the European Medicines Agency (EMA) at the end of December 2010, Dr Thomas Lönngren has moved to the NDA Group as a strategic advisor in its newly launched business.

The company's new regulatory and market access firm, NDA Advisory Services, aims to slash rising costs and address the challenges of drug regulation and reimbursement, to ensure new medicines can get to patients faster.

Dr Lönngren will use his 30 years' experience in the regulatory field to help create a coordinated approach to Health Technology Assessment (HTA) and improve the market access situation in Europe.

"I've recognised for a long time that the whole area of market access needs new ideas and a new vision. I plan to further develop my ideas surrounding International Regulatory Strategies, coupled with pushing for a joined-up approach to HTA, to enable the best medicines to reach needy patients as efficiently as possible," he commented.

Tony Baker, vice president of the NDA Group, said: "The route to market is extremely complex and expensive and many products fail because companies do not fully address the needs to demonstrate the quality, safety and efficacy of their products and also to adapt to the European reimbursement systems. Many new drug developments terminate before they even reach the regulators. And even if a product gains approval, the industry faces great challenges over pricing and reimbursement from regional agencies. This prevents many potential groundbreaking medicines from ever reaching patients."

Meanwhile, the current head of administration at the EMA, Andreas Pott, holds the position of acting executive director while the recruitment procedure for a new executive director for the agency is completed. He has been head of administration since May 2000.

19th January 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics